Pharma News

Dr. Reddy’s Laboratories in a statement issued said that it has been made aware of an order passed by the District Court of Delaware, USA, granting a Temporary Restraining Order (TRO) with immediate effect on sales, delivery, transfer, or other disposition of its generic esomeprazole product in the US market.

[adsense:336x280:8701650588]

Immune Pharmaceuticals Inc. announced that the US Food and Drug Administration (FDA) accepted the company's Investigational New Drug (IND) application for its first in class, lead product candidate, Bertilimumab, for the treatment of Bullous Pemphigoid (BP). This FDA acceptance enables the company to expand recruitment for its clinical trials.

Drugmaker Gilead Sciences Inc said U.S. Food and Drug Administration had approved the expanded use of its blockbuster hepatitis C drug, Harvoni. The drug can now be used to treat patients with subtypes of chronic hepatitis C virus (HCV) and patients who are co-infected with Human Immunodeficiency Virus (HIV), Gilead said in a statement. Gilead's Harvoni was first approved by the FDA in October 2014.

Boehringer Ingelheim today announced it has completed enrollment for the pivotal Phase III trial of BI695501, a biosimilar candidate to adalimumab (AbbVie’s Humira®). This announcement was made following recent results from a Phase I trial that demonstrated pharmacokinetic bioequivalence with both the U.S.-licensed and EU-approved reference products.These Phase I data for BI695501 were discussed at the American College of Rheumatology / Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting in San Francisco.

Staying up late and not getting six hours of sleep puts one at high risk of becoming a Type-II diabetic, a disease once believed to be caused primarily by being overweight, prominent diabetes experts say.

A whopping 66.11 percent of Indian children possess "abnormal levels of sugar" in their body, reveals a new nationwide three-year-long survey, the results of which were released here on Friday.

Of the eight million cancer deaths worldwide in 2012, five million occurred in middle-income countries and 500,000 in low-income countries, says a new study led by an Indian-origin researcher.

The rate of new HIV infections rises significantly in the five years leading up to violent conflict in a country, says a new study. The researchers looked into the relationship between bloodshed and HIV incidence in sub-Saharan Africa.

UBM India is all set to host the 3rd Annual India Pharma Awards scheduled on 30th November, 2015 at ITC Maratha, Mumbai and pleased to announce TAKE Solutions as our presenting partner. The event is more than an ‘Award Night’ and it will bring together the luminaries of the Pharmaceutical Industry combined with a night of glamour, entertainment, jubilation and the pride of being the crème de la crème of the Indian Pharmaceutical sector.

Children of poverty stricken families suffer lags in brain development and score as much as 20 per cent lower on cognitive tests, a new study has found. Low-income children had atypical structural brain development and lower standardised test scores, with as much as an estimated 20 per cent in the achievement gap explained by development lags in the frontal and temporal lobes of the brain, researchers said. Socioeconomic disparities in school readiness and academic performance are well documented but little is known about the mechanisms underlying the influence of poverty on children's learning and achievement.